Molecular markers of myeloma cell sensitivity vs. resistance to heterobifunctional degraders of oncoproteins: therapeutic implications Breadcrumbs UL Home Research Publications Year of Publication 2019 Journal Clinical Lymphoma Myeloma And Leukemia DOI 10.1016/J.CLML.2019.09.222